Regional Lipolysis Insulin Regulation - Trial NCT06392854
Access comprehensive clinical trial information for NCT06392854 through Pure Global AI's free database. This Phase 1 trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Obesity. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mayo Clinic
Timeline & Enrollment
Phase 1
Jun 01, 2024
Jul 01, 2028
Primary Outcome
palmitate release
Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to
 insulin in the same way as lean adults. Researchers are trying to understand why fat tissue
 responds differently in people with different body types.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06392854
Non-Device Trial